Background—Although most clinical trials of coronary stents have measured nominally
identical safety and effectiveness end points, differences in definitions and timing of …

Dual antiplatelet therapy with aspirin and a thienopyridine has been shown to reduce
cardiac events after coronary stenting. However, many patients and healthcare providers …

Background—Stent thrombosis is a lethal complication of endovascular intervention.
Concern has been raised about the inherent risk associated with specific stent designs and …

Objectives: This study examined human drug-eluting stents (DES) to determine the long-
term effects of these stents on coronary arterial healing and identified mechanisms …

ContextTraditionally, stent thrombosis has been regarded as a complication of percutaneous
coronary interventions during the first 30 postprocedural days. However, delayed …

Objectives: This study sought to comprehensively identify predictors of stent thrombosis (ST).
Background: Given the devastating consequences of ST, efforts should be directed toward …

Although rare, stent thrombosis remains a severe complication after stent implantation owing
to its high morbidity and mortality. Since the introduction of drug-eluting stents (DES), most …

1440 and clinical studies, we propose that the pathophysiological mechanisms known as
Virchow's triad may be responsible for LST with gen1-DES. 53 Furthermore, we comment on …

Over the past two decades, significant advancements have been made regarding the
material formulation, iterative design, and clinical translation of metallic bioresorbable stents …

Background—There are limited studies of stent thrombosis in the modern era of second-
generation stents, high-pressure deployment, and current antithrombotic regimens. Methods …